Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Liu, Shen & AssociatesAn increasing number of foreign companies are conducting research and development in China. Xuelan Yue of Liu Shen & Associates considers the implications and how to incentivise inventors -
Sponsored by FirstLaw PCDong Uk Lee of FirstLaw PC analyses the results from the first five years of implementation of the ex parte revocation procedure in Korea, including the rates of dismissal and claim amendment
-
Sponsored by Remfry & SagarSurendra Sharma and Udayvir Rana of Remfry & Sagar report on the successful introduction of the Intellectual Property Division in Delhi and regional legislation that should serve as an example for the rest of India
-
Sponsored by Hechanova GroupEditha R. Hechanova, Noemi P. Rivera, and Joy Marie G. Tolentino of Hechanova Group answer the most important questions relating to the registration of trademarks in the Philippines, including via the Madrid System
-
Sponsored by Bugnion SpACristina Biggi of Bugnion shares her expertise on second medical use patents in Europe, focusing particularly on recent case law from Italy
-
Sponsored by CASPeter Blasi, Global Strategic Account Manager for the CAS Ionic Affinity Program, talks to Managing IP about prior art patent searches, sharing his advice on maximising both thoroughness and efficiency
